Tri-Med Americas
Tri-Med's purpose is to facilitate the detection and treatment of H.pylori globally.
Tri-Med is an Australian based business founded in 1996 by Nobel Prize winner, Professor Barry Marshall to satisfy a need for the development of a reliable diagnostic test to detect H.pylori.
Today, Tri-Med has expanded both its product base and international footprint. From our office in the United States, we market PYtest, scintillation and collection fluids and associated therapeutics throughout North and South America.
For further information about the detection and treatment of H.pylori, you should consult your doctor or healthcare professional.
The greatest obstacle to knowledge is not ignorance, it is the illusion of knowledge
- Daniel Boorstin (Librarian for the US Congress; Historian)
The Founder and Inventors
Barry J. Marshall
Natural curiosity and the ability to challenge status quo thinking were attributes that led a young doctor into the field of gastroenterology, more specifically a project in conjunction with Dr Robin Warren researching stomach bacteria.
In the spirit of Aussie entrepreneurship Professor Marshall famously ingested the H.pylori bacteria in an effort to prove that he had a cure. Who would have thought that single act of bravery could have resulted in a cure for stomach ulcers which has helped millions of people around the world.
Read the full story